| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.004 |
| mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
0.005 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.005 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.005 |